SCHEMBL24486807

SCHEMBL24486807

O=c1oc2ccccc2cc1CNCS(=O)(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.64
MAOA P21397 2/20 0.64
MMP2 P08253 1/20 0.52
MMP9 P14780 1/20 0.52
ADAM17 P78536 1/20 0.52
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
LMNA P02545 1/20 0.48
MAPK1 P28482 1/20 0.48
TYR P14679 1/20 0.47
DAO P14920 1/20 0.47
AKR1B1 P15121 1/20 0.47
HPGD P15428 1/20 0.47
CA12 O43570 4/20 0.47
CA9 Q16790 3/20 0.47
CA1 P00915 3/20 0.47
CA2 P00918 2/20 0.47
NPC1 O15118 3/20 0.44
RAB9A P51151 2/20 0.44
CA4 P22748 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24487272 0.88 MAOB (0.67) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL24486808 0.85 MAOB (0.51) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL29234432 0.80 MAOB (0.64) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL24487169 0.79 MMP2 (0.52) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL3009674 0.78 HPGD (0.59) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL21172143 0.77 MAOB (0.51) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL24487222 0.77 MMP2 (0.44) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL3237481 0.77 MAOB (0.64) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL29941904 0.77 MAOB (0.68) MAOBMAOAMMP2MMP9ADAM17
SCHEMBL24486866 0.76 MMP2 (0.48) MAOBMAOAMMP2MMP9ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352325-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals WATERS TECHNOLOGIES CORPORATION (US) 2022-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352325-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals FUT5, FUT6, ST3GAL3 MAOB 1517/4885MAOA 2214/4885MMP2 790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.